LYNNDOH VALMORES: Open Payments
NPI 1265903116 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,522 in 96 payments from 18 companies in 2025. Trend: 2023 $1,542 · 2024 $2,641 · 2025 $2,522
Food & beverage: $2,345Education: $177
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $492 |
| Galderma Laboratories, L.P. | 9 | $421 |
| GENZYME CORPORATION | 9 | $266 |
| LEO Pharma Inc. | 7 | $215 |
| ABBVIE INC. | 11 | $208 |
| Biofrontera Inc. | 2 | $202 |
| Regeneron Healthcare Solutions, Inc. | 7 | $143 |
| Incyte Corporation | 6 | $111 |
| Lilly USA, LLC | 4 | $96 |
| PFIZER INC. | 6 | $93 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, SKYRIZI, ADBRY, OPZELURA, CIBINQO, TALTZ.
Industry payments across AZ — which companies pay providers there.
